Symtuza 800-150-200-10 MG tab UU 30S
Ended Awarded
- Contract number
- SPE2DB25FXA17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,031
Award facts
- Contract value 100% obligated
- $28,030.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,030.67 to AmerisourceBergen Drug Corp for the supply of Symtuza 800-150-200-10 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was finalized on August 26, 2025, with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly fulfills orders through the DLA Medical Supply Chain to support military and veteran healthcare systems. The company's federal contract portfolio encompasses a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for Symtuza, an antiretroviral medication, exemplifies the routine pharmaceutical procurement activities managed under the broader SPE2DX prime vendor agreement, which enables AmerisourceBergen to supply essential medications and medical commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FXA17?
SPE2DB25FXA17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FXA17 worth?
The government has obligated $28,031 on SPE2DB25FXA17.
Is contract SPE2DB25FXA17 an order under another contract?
Yes. SPE2DB25FXA17 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXA17 competed?
The extent of competition for SPE2DB25FXA17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award